Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
03/09/1991 | WO1991003489A1 Structural alterations of the egf receptor gene in human gliomas |
03/09/1991 | WO1991003483A1 Tsh receptor |
03/09/1991 | CA2024918A1 Fused proteins and production thereof |
03/08/1991 | WO1991003555A1 Interleukin-4 receptors |
03/08/1991 | CA2066240A1 Interleukin-4 receptors |
03/08/1991 | CA2024697A1 Protein having anticoagulant properties |
03/07/1991 | WO1991002807A1 Production of biologically active insulin-like growth factor i from high expression host cell systems |
03/07/1991 | WO1991002796A1 Cystic fibrosis gene |
03/07/1991 | WO1991002756A1 Prohormone cleavage site blocking antibody |
03/07/1991 | WO1991002754A1 Fusion proteins comprising gm-csf and il-3 |
03/07/1991 | WO1991002753A1 Anticoagulant protein |
03/07/1991 | WO1991002751A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs |
03/07/1991 | WO1991002748A1 Rubella e1 peptides |
03/07/1991 | WO1991002540A1 Compositions for the inhibition of protein hormone formation and uses thereof |
03/07/1991 | WO1991000920A3 Process for preparing a protein by a fungus transformed by multicopy integration of an expression vector |
03/07/1991 | DE3928861A1 Monoclonal antibodies specific for interleukin 8 - reagents for quantitative sandwich ELISA and affinity purificn. |
03/07/1991 | CA2005398A1 Alginase and a process for production thereof and bacteria used, as well as a method for decomposition of alginic acid |
03/06/1991 | EP0415801A1 Monoclonal antibodies against activated microglial cells |
03/06/1991 | EP0415565A2 Enhanced expression of heterologous proteins in recombinant hosts in a non-growth media |
03/06/1991 | EP0415557A2 Separation of anti-metal chelate antibodies |
03/06/1991 | EP0415470A2 Aminopeptidase |
03/06/1991 | EP0415321A1 Oligodendrocyte cytotoxic factor |
03/06/1991 | EP0415219A1 ANF-Antagonist |
03/06/1991 | EP0414921A1 Human monoclonal antibody reactive with pseudomonas aeruginosa, cell which produces the antibody, method of production, and pharmaceutical preparation |
03/06/1991 | EP0414812A1 Extraction of human interleukin-4 from bacteria |
03/06/1991 | EP0414807A1 Human mammary cell growth inhibitor and methods of production and use |
03/06/1991 | EP0414728A1 NOVEL NEUTROPHIL CHEMOTACTIC FACTOR, CLONED cDNA AND MONOCLONAL ANTIBODIES THERETO |
03/06/1991 | EP0162054B1 Production of cdna representing hepatitis a viral sequences |
03/05/1991 | WO1991003570A1 Monoclonal antibody against infectious pancreatic nephrosis virus having neutralizing activity |
03/05/1991 | US4997915 Purification of pertussis toxins |
03/05/1991 | CA2039168A1 Neutralizing monoclonal antibody to infectious pancreatic necrosis virus |
03/05/1991 | CA2024145A1 Expression plasmids and use thereof |
03/02/1991 | CA2024053A1 Anf-antagonist |
03/01/1991 | WO1991003738A1 Immunochemical reagents and methods for monitoring industrial fermentation |
03/01/1991 | WO1991003484A1 Abo genotyping |
03/01/1991 | CA2065352A1 Abo genotyping |
03/01/1991 | CA2039178A1 Reactives and immunochemical methods for measuring microorganisms growing and proteins quantity during industrial fermentation |
03/01/1991 | CA2024030A1 Oligodendrocyte cytotoxic factor |
02/27/1991 | EP0414374A2 Novel antigens and methods for their preparation |
02/27/1991 | EP0414355A1 Feline interferon and process for production thereof by a silkworm virus vector |
02/27/1991 | EP0414297A1 Efficient production of mutant proteases |
02/27/1991 | EP0414178A2 Non-human primate CD4 polypeptides and human CD4 molecules capable of being glycosylated |
02/27/1991 | EP0414134A1 Method for producing antiviral protein utilizing E.coli transformant, and gene and E.coli vector used in the method |
02/27/1991 | EP0414035A2 Gibbon ape leukemia virus receptor |
02/27/1991 | EP0413967A1 Novel antibiotic |
02/27/1991 | EP0413908A2 Soluble extracellular fragment of the human IFN-beta 2/IL-6 receptor, its preparation and pharmaceutical compositions containing it |
02/27/1991 | EP0413818A1 Process for producing a human neutrophil chemotactic factor polypeptide. |
02/27/1991 | EP0413794A1 Periodontal and bone regeneration factor, materials and methods |
02/27/1991 | EP0413762A1 Peptide analogs and their use as haptens to elicit catalytic antibodies |
02/27/1991 | EP0413738A1 Vectors encoding hcmv glycoprotein and expression products |
02/27/1991 | EP0413721A1 Human gm-csf variants |
02/27/1991 | CN1049524A Process for production of hydrolyzed vegestable proteins and product therefrom |
02/27/1991 | CN1049523A Escherichia coli vaccine |
02/27/1991 | CN1049522A Fermentation extraction of fugu peptide and its determination |
02/26/1991 | US4996297 contraceptives for non-rodent mammals |
02/26/1991 | US4996148 Aerobic fermentation of Kibdelosporangium |
02/26/1991 | CA2023969A1 Production of biologically active insulin-like growth factor i from high expression host cell systems |
02/26/1991 | CA1280693C Purification of pertussis antigens |
02/25/1991 | CA2023819A1 Gibbon ape leukemia virus receptor |
02/24/1991 | WO1991002977A1 Wound healing preparations containing heparanase |
02/24/1991 | WO1991002743A1 Non-human primate cd4 polypeptides, fusions thereof, dna encoding, and uses thereof |
02/24/1991 | CA2065744A1 Wound healing preparations containing heparanase |
02/24/1991 | CA2065010A1 Non-human primate cd4 polypeptides, fusions thereof, dna encoding, and uses thereof |
02/22/1991 | WO1991002744A1 Bone-specific protein |
02/22/1991 | CA2064878A1 Bone-specific protein |
02/21/1991 | WO1991002252A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
02/21/1991 | WO1991002079A1 Monoclonal antibodies against a tumor-associated antigen |
02/21/1991 | WO1991002078A1 Tumour necrosis factor binding ligands |
02/21/1991 | WO1991002074A1 Method for obtaining polypeptides in a cell-free translation system |
02/21/1991 | WO1991002066A1 Production of heterologous proteins in plants and plant cells |
02/21/1991 | WO1991002063A1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
02/21/1991 | WO1991002062A2 C-erbb-2 external domain: gp75 |
02/21/1991 | WO1991002061A1 Recombinant human thyroid peroxidase |
02/21/1991 | WO1991002058A1 Production of vascular endothelial cell growth factor |
02/21/1991 | WO1991001744A2 Uses of interleukin-4 and method for purifying it |
02/21/1991 | WO1991001743A1 Stabilized protein or peptide conjugates |
02/21/1991 | WO1991001639A1 Methods and compositions for ameliorating the symptoms of sepsis |
02/21/1991 | CA2064753A1 Uses of interleukin-4 and method for purifying it |
02/21/1991 | CA2060663A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
02/20/1991 | EP0413622A1 Albumin derivatives with therapeutic functions |
02/20/1991 | EP0413477A1 Monoclonal Antibody |
02/20/1991 | EP0413383A1 Mutants of human interleukin-3 |
02/20/1991 | EP0413378A1 Escherichia coli vaccine |
02/20/1991 | EP0413024A1 Protein having activity of inhibiting inflammation-inducing phospholipase a2 |
02/20/1991 | EP0412970A1 Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein |
02/19/1991 | WO1991002755A1 Fibulin |
02/19/1991 | WO1991002546A1 A reagent for the detection of fibrinolytic activity |
02/19/1991 | US4994565 Nucleotide sequence of gene specifically expressed by insulinoma |
02/19/1991 | US4994556 Antitumor agents |
02/19/1991 | US4994555 Process for recovery of glycopeptidic antibiotics |
02/19/1991 | US4994554 Probursin |
02/19/1991 | US4994380 Transducing replicable plasmid into cell |
02/19/1991 | US4994369 T-cell activation related gene |
02/19/1991 | US4994271 BMY-40800 antitumor antibiotics |
02/19/1991 | CA2065147A1 Reagent for the detection of fibrinolytic activity |
02/19/1991 | CA2064818A1 Fibulin |
02/19/1991 | CA1280379C Peptides and compositions |
02/19/1991 | CA1280363C Peptide composition and method for the detection of antibodies to htlv-iii |
02/17/1991 | CA2020700A1 Compositions for the inhibition of protein hormone formation and uses thereof |
02/16/1991 | CA2023250A1 Cleavage site blocking antibody to prohormone proteins and uses thereof |